Incidence and survival of ocular melanoma in National Cancer Registry of Poland in 2010-2017

Adv Clin Exp Med. 2022 Jun;31(6):615-621. doi: 10.17219/acem/146581.

Abstract

Background: Oncology trends are based on data coming from different countries and ocular melanoma is the most common primary eye cancer in adults.

Objectives: To investigate the incidence and characteristics of ocular melanoma in the overall population of Poland.

Material and methods: The retrospective survey of both the National Cancer Registry (NCR) and National Health Fund (NHF) databases was performed to identify all ocular melanoma cases in Poland in 2010-2017.

Results: The mean incidence of ocular melanoma was 8.76/1,000,000 person-years; the lowest incidence was observed in the 19-29 age group (1.17/1,000,000 person-years) and the highest in the group over 70 (22.88/1,000,000 person-years). There were no statistically significant trends in the incidence rates over the study period. The overall incidences of uveal, eyelid and conjunctival melanoma were 6.67/1,000,000, 0.47/1,000,000 and 0.28/1,000,000 person-years, respectively. The 5-year overall survival (OS) was 60.76%; the higher risk of death was associated with male sex (hazard ratio (HR) = 1.2959), older age at diagnosis (HR = 1.0379), chemotherapy treatment (HR = 1.6774), metastasis (HR = 1.5716), loco-regional hyperplasia (HR = 1.5936), and systemic tumor spread (HR = 3.9872), compared to the carcinoma in situ. The risk of death was reduced by radiotherapy treatment (HR = 0.6645).

Conclusions: The incidence rate of ocular melanoma in Poland is in the middle of the range worldwide, and the 5-year OS is relatively low.

Keywords: ocular melanoma; patient survival; radiotherapy.

MeSH terms

  • Adult
  • Eye Neoplasms* / epidemiology
  • Eye Neoplasms* / therapy
  • Humans
  • Incidence
  • Male
  • Melanoma* / epidemiology
  • Melanoma* / pathology
  • Melanoma* / therapy
  • Poland / epidemiology
  • Registries
  • Retrospective Studies
  • Survival Rate